Results 91 to 100 of about 636,200 (242)

Therapeutic‐dose verapamil‐induced cardiogenic shock in an older patient: a case report

open access: yesJournal of Pharmacy Practice and Research, EarlyView.
Abstract Background Calcium channel blocker (CCB) toxicity most commonly follows deliberate overdose. However, severe toxicity at therapeutic doses may occur in susceptible individuals. Severe CCB toxicity often presents with clinical features of bradycardia, hypotension, hyperglycaemia, and lactic acidosis.
Christopher Thuring   +3 more
wiley   +1 more source

Sleep‐disordered breathing in valvular heart disease: A Modifiable comorbidity

open access: yesSleep Research, EarlyView.
Abstract Sleep‐disordered breathing (SDB) is highly prevalent among patients with valvular heart disease (VHD) and is independently associated with adverse clinical outcomes. The two major phenotypes—obstructive sleep apnea (OSA) and central sleep apnea (CSA)—exhibit distinct distributions across VHD subtypes. CSA predominates in severe aortic stenosis,
Wu Juan   +6 more
wiley   +1 more source

Reoperative aortic valve replacement in the era of valve‐in‐valve procedures

open access: yesClinical Case Reports, 2020
Current evidence suggests that the choice between valve‐in‐valve transcatheter aortic valve implantation and reoperative aortic valve replacement should be based on multiple factors.
Daisuke Kaneyuki   +3 more
doaj   +1 more source

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Musclin (osteocrin) is a skeletal muscle‐derived peptide that has been implicated in cardioprotective signalling pathways. Its relevance in cancer patients, who frequently experience muscle wasting and cardiotoxicity, remains unclear. This study aimed to determine whether circulating Musclin levels reflect functional capacity and
Jannek Brauer   +5 more
wiley   +1 more source

Neurological Complications after Transcatheter Aortic Valve Implantation Procedure

open access: yesPielęgniarstwo Neurologiczne i Neurochirurgiczne
Aortic stenosis is the most common primary valvular heart disease in both Europe and North America. In patients with symptomatic severe aortic stenosis, early surgical treatment is recommended because of the very poor prognosis and the lack of effect of ...
Daniel Rogowicz   +7 more
doaj   +1 more source

Cost effectiveness of aortic valve therapies: a systematic review of the literature

open access: yesEpidemiology, Biostatistics and Public Health, 2013
Background: we performed a systematic review on the cost effectiveness of transcatheter aortic valve implantation (TAVI) to standard aortic valve replacement and medical management in high-risk elderly patients with severe aortic stenosis.Methods: in ...
Suzanne Battaglia   +2 more
doaj   +1 more source

Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older

open access: yesJournal of the American Geriatrics Society, EarlyView.
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet   +4 more
wiley   +1 more source

Transcatheter Aortic Valve Implantation in Alkaptonuria-Аssociated Severe Aortic Stenosis: A 2.5-Year Follow-Up Case Report and Literature Review

open access: yesLife
Introduction: Alkaptonuria is an autosomal-recessive disorder affecting the metabolism of tyrosine and phenylalanine which results in accumulation of homogentisic acid in connective tissues.
Spas Kitov   +5 more
doaj   +1 more source

Leadless Pacemaker Implantation in High‐Risk Patients: Real‐World Outcomes From a Multicenter Israeli Registry

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz   +7 more
wiley   +1 more source

Device Selection for Transcatheter Aortic Valve Implantation

open access: yes, 2022
Twenty years after the first implantation by Alain Cribier and his team, transcatheter aortic valve implantation (TAVI) has demonstrated its efficacy and safety in patients with symptomatic severe aortic stenosis with high, intermediate, and even low ...
Camille Granger, Paul Guedeney
core   +1 more source

Home - About - Disclaimer - Privacy